ESPR stock results show that Esperion Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
Articles
HSIC Stock Earnings: Henry Schein Beats EPS, Misses Revenue for Q1 2024
HSIC stock results show that Henry Schein beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
GEO Stock Earnings: GEO Group Misses EPS, Beats Revenue for Q1 2024
GEO stock results show that GEO Group missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More
CELH Stock Earnings: Celsius Holdings Beats EPS, Misses Revenue for Q1 2024
CELH stock results show that Celsius Holdings beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
ATKR Stock Earnings: Atkore Beats EPS, Misses Revenue for Q2 2024
ATKR stock results show that Atkore beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
OSCR Stock Earnings: Oscar Health Beats EPS, Beats Revenue for Q1 2024
OSCR stock results show that Oscar Health beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
MD Stock Earnings: Pediatrix Medical Group Beats EPS, Misses Revenue for Q1 2024
MD stock results show that Pediatrix Medical Group beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
